4:21 PM
 | 
Sep 13, 2013
 |  BC Extra  |  Company News

Plexcera licenses recombinant ceramidase from Mount Sinai

The Icahn School of Medicine at Mount Sinai Hospital (New York, N.Y.) granted Plexcera Therapeutics LLC (Vero Beach, Fla.) exclusive, worldwide rights to develop and commercialize...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >